| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/19/2012 | US20120015964 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/19/2012 | US20120015961 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity |
| 01/19/2012 | US20120015943 Substituted hydroxamic acids and uses thereof |
| 01/19/2012 | US20120014997 Aryl sulfonamides |
| 01/19/2012 | US20120014913 Process for preparing antiviral compounds |
| 01/19/2012 | DE10229505B4 Flüssigkristalline Mischungen und ihre Verwendung Liquid-crystalline mixtures and their use |
| 01/19/2012 | CA2805748A1 Process for preparing antiviral compounds |
| 01/19/2012 | CA2802313A1 1-hydroxyimino-3-phenyl-propanes |
| 01/19/2012 | CA2801032A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| 01/18/2012 | EP2407469A1 Salt of sitagliptin |
| 01/18/2012 | EP2406262A1 Prodrug forms of kinase inhibitors and their use in therapy |
| 01/18/2012 | EP2406240A2 Inhibitors of beta-secretase |
| 01/18/2012 | EP2406236A1 Rho kinase inhibitors |
| 01/18/2012 | EP2406235A2 Process for the preparation of bosentan |
| 01/18/2012 | EP2406234A1 Thiazole sulfonamide and oxazole sulfonamide kinase inhibitors |
| 01/18/2012 | EP2406233A1 Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
| 01/18/2012 | EP2406222A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 01/18/2012 | EP2406221A2 Sodium salt of 5-cyclopropyl-2-{ý2-(2,6- difluorophenyl)pyrimidin-5-yl¨amino}benzoic acid as dhodh inhibitor |
| 01/18/2012 | CN102321033A Preparation method of tarceva |
| 01/18/2012 | CN102321032A Preparation method of quinazoline derivate |
| 01/18/2012 | CN102321031A Polysubstituted 4, 6-distyryl pyrimidine compound and preparation method and application thereof |
| 01/17/2012 | USRE43115 Process for the manufacture of fused piperazin-2-one derivatives |
| 01/17/2012 | US8097759 Inflammatory cytokine release inhibitor |
| 01/17/2012 | US8097758 Isoserine derivatives for use as coagulation factor IXa inhibitors |
| 01/17/2012 | US8097630 Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors |
| 01/17/2012 | US8097611 Sulfonyl-derivatives as novel or histone deacetylase |
| 01/17/2012 | US8097236 The invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable |
| 01/17/2012 | CA2537587C Superhigh purity ionic liquid |
| 01/12/2012 | US20120010172 Novel urea and thiourea derivatives |
| 01/11/2012 | EP2404907A1 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| 01/11/2012 | EP2404905A1 New compounds |
| 01/11/2012 | EP2404603A1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases |
| 01/11/2012 | EP2403837A1 3-arylquinazolin-4-one compounds for combating invertebrate pests |
| 01/11/2012 | EP2403836A2 Brush polymer coating by in situ polymerization from photoreactive surface |
| 01/11/2012 | EP1994005B9 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents |
| 01/11/2012 | EP1802591B1 Quinazoline derivatives |
| 01/11/2012 | EP1763518B1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/11/2012 | EP1458687B1 Pyrimidine compounds as interleukin-12 (il-12) inhibitors |
| 01/11/2012 | EP1334968B1 Process for producing substituted aniline compound |
| 01/11/2012 | CN1989140B Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation |
| 01/11/2012 | CN102317269A Novel amino azaheterocyclic carboxamides |
| 01/11/2012 | CN102317268A 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors |
| 01/11/2012 | CN102317267A Process for the preparation of rosuvastatin salts |
| 01/11/2012 | CN102317266A 6-phenylpyrimidinones as PIM modulators |
| 01/11/2012 | CN102317265A 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders |
| 01/11/2012 | CN102317263A Halogen-substituted compounds as pesticides |
| 01/11/2012 | CN102311395A Quinazoline ring substituted diphenylurea derivative and its purpose |
| 01/11/2012 | CN102311394A Preparation method for 5-ethyl-5-phenyl barbituric acid |
| 01/11/2012 | CN102311393A Preparation method of sulfadoxine |
| 01/11/2012 | CN102311392A Synthetic method of azoxystrobin and special intermediate for synthesis |
| 01/11/2012 | CN102070537B Rosuvastatin calcium compound and novel refining method thereof |
| 01/11/2012 | CN101600698B Quinazolinone and isoquinolinone acetamide derivatives |
| 01/10/2012 | USRE43098 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093386 Thioaryl substituted inhibitors of zinc proteases and their use |
| 01/10/2012 | US8093385 Leukotriene B4 inhibitors |
| 01/10/2012 | US8093384 Processes for the preparation of alfuzosin |
| 01/10/2012 | US8093254 Aspartyl protease inhibitors |
| 01/10/2012 | US8093245 Anticancer agents; potent Deoxycytidine kinase inhibitors; inhibit thymidine kinase; inhibit uridine kinase; N-[3-(4-amino-5-fluoro-2-oxo-2H-pyrimidin-1-yl)-cyclopentyl]-3-bromo-benzenesulfonamide |
| 01/10/2012 | US8093239 Imidazopyridine kinase inhibitors |
| 01/10/2012 | CA2557781C 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 01/10/2012 | CA2436665C Nucleic acid derivatives |
| 01/05/2012 | WO2012003497A1 Napht- 2 -ylacetic acid derivatives to treat aids |
| 01/05/2012 | WO2012002741A2 Process for the preparation of hmg-coa reductase inhibitors and intermediates thereof |
| 01/05/2012 | WO2012002539A1 Novel noncrystalline bosentan and process for preparation thereof |
| 01/05/2012 | WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof |
| 01/05/2012 | WO2012001969A1 Aromatic amine derivative, and organic electroluminescent element comprising same |
| 01/05/2012 | WO2012000304A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 01/05/2012 | WO2012000182A1 Quinazoline compounds |
| 01/05/2012 | WO2011112428A3 Arylvinylazacycloalkane compounds for constipation |
| 01/05/2012 | WO2010139180A8 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 01/05/2012 | WO2010089753A3 Novel polymorphs of lopinavir |
| 01/05/2012 | US20120004592 Compositions for solubilizing tissue |
| 01/05/2012 | US20120004249 The polymorph forms of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof |
| 01/05/2012 | US20120004244 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004243 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 01/05/2012 | US20120003229 Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapy |
| 01/05/2012 | US20120003184 Sodium salt of 5-cyclopropyl-2-benzoic acid as dhodh inhibitor |
| 01/05/2012 | US20120003183 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 01/05/2012 | US20120001154 Aromatic amine derivative and organic electroluminescence device using the same |
| 01/05/2012 | CA2804347A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 01/05/2012 | CA2803848A1 A process for etravirine intermediate and polymorphs of etravirine |
| 01/05/2012 | CA2802308A1 Napht-2-ylacetic acid derivatives to treat aids |
| 01/04/2012 | EP2402326A1 Crystals of hydrochloride salts of a Phenylalanine Derivative, Production Method Thereof and Use Thereof as alpha4 integrin Inhibitors |
| 01/04/2012 | EP2402325A2 Hydroxylated and methoxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors |
| 01/04/2012 | EP2402320A1 Anorectic agents |
| 01/04/2012 | EP2402319A1 DGAT Inhibitors |
| 01/04/2012 | EP2402318A1 DGAT inhibitors |
| 01/04/2012 | EP2402310A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402309A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2401256A1 Compounds as bradykinin b1 antagonists |
| 01/04/2012 | EP2155694B1 Triazinone and diazinone derivatives useful as hsp90 inhibitors |
| 01/04/2012 | EP2049502B1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/04/2012 | EP1928461B1 Pyrimidine compounds as serotonin receptor modulators |
| 01/04/2012 | CN102307864A New process for the preparation of nitroorotic acid |
| 01/04/2012 | CN102307863A Pyrimidine derivatives, horticultural insecticides comprising said derivatives and method of use thereof |
| 01/04/2012 | CN102304095A Preparation method of sulfadoxine |
| 01/04/2012 | CN102304094A Preparation method of sulfadoxine and intermediate thereof |
| 01/04/2012 | CN102304093A Process for producing sulfadimidine |
| 01/04/2012 | CN102304092A Production process of sulfadiazine sodium |